Renewing Naglazyme (Galsulfase) Approval with Aetna (CVS Health) in Florida: Complete Guide to Prior Authorization Renewal
Answer Box: Renewing Naglazyme (Galsulfase) Coverage with Aetna (CVS Health) in Florida
Aetna requires annual prior authorization renewal for Naglazyme (galsulfase) with documented clinical response to therapy. Start your renewal 60-90 days before expiration to avoid treatment gaps. Key requirements include: (1) confirmation of clinically positive response showing improvement, stabilization,